Documents
Application Sponsors
NDA 209627 | THERAPEUTICSMD INC | |
Marketing Status
Application Products
001 | RING;VAGINAL | 0.013MG/24HR;0.15MG/24HR | 1 | ANNOVERA | ETHINYL ESTRADIOL; SEGESTERONE ACETATE |
FDA Submissions
TYPE 1/4; Type 1 - New Molecular Entity and Type 4 - New Combination | ORIG | 1 | AP | 2018-08-10 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2022-04-29 | STANDARD |
Submissions Property Types
CDER Filings
THERAPEUTICSMD INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209627
[companyName] => THERAPEUTICSMD INC
[docInserts] => ["",""]
[products] => [{"drugName":"ANNOVERA","activeIngredients":"ETHINYL ESTRADIOL; SEGESTERONE ACETATE","strength":"0.013MG\/24HR;0.15MG\/24HR","dosageForm":"RING;VAGINAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"08\/10\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209627s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"08\/10\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity and Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209627s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209627Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/209627Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2018-08-10
)
)